Publications by authors named "Athanassios Argiris"

Claim this Profile
E
Extracellular Matrix-MYCAF Signatures Correlate with Resistance to Neoadjuvant aPD-L1 Immune Checkpoint Inhibition with Durvalumab + Metformin in HPV+ HNSCC.
Pablo Llerena, Hani Samarah, Kathryn Nunes, Zhao Lin, Kelly Bridgham, Athanassios Argiris

Clin Cancer Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant nivolumab plus carboplatin and paclitaxel in patients with locally advanced resectable squamous cell carcinoma of the head and neck: a phase II, single-arm trial.
Ralph G Zinner, Eric V Mastrolonardo, Jennifer M Johnson, Kathryn Nunes, Pablo Llerena, Athanassios Argiris

Clin Cancer Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response-Adaptive Surgical Timing in Neoadjuvant Immunotherapy Demonstrates Enhanced Pathologic Treatment Response in Head and Neck Squamous Cell Carcinoma.
Eric V Mastrolonardo, Kathryn L Nunes, Pablo Llerena, Anastasia Nikitina, Anastasia Sobol, Athanassios Argiris

Clin Cancer Res· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive capacity of immune-related adverse events and cytokine profiling in neoadjuvant immune checkpoint inhibitor trials for head and neck squamous cell carcinoma.
Angela E Alnemri, Sruti Tekumalla, Annie E Moroco, Ioannis Vathiotis, Madalina Tuluc, Athanassios Argiris

Cancer Med· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of preoperative programmed death-1 or programmed death ligand-1 immune check point inhibition on complications after surgery for primary head and neck cancer.
Ramez Philips, Angela Alnemri, Dev Amin, Jena Patel, Michael C Topf, Athanassios Argiris

Cancer· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new prognostic model in chemotherapy-treated patients with recurrent or metastatic head and neck cancer: An analysis of ECOG-ACRIN E1305.
Athanassios Argiris, Yael Flamand, Panayiotis Savvides, Jennifer M Johnson, Ioannis Vathiotis

Eur J Cancer· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of a gene-expression subtype to outcome and treatment response in patients with recurrent/metastatic head and neck squamous cell carcinoma treated with nivolumab.
Mara Serena Serafini, Stefano Cavalieri, Lisa Licitra, Federico Pistore, Deborah Lenoci, Athanassios Argiris

J Immunother Cancer· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In-Field Toxicity Analysis of a Phase 1 Clinical Trial of Nivolumab and Ipilimumab With Definitive Radiation Therapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck.
Ayesha S Ali, Gregor Manukian, Jennifer M Johnson, Ioannis Vathiotis, Rita Axelrod, Athanassios Argiris

Int J Radiat Oncol Biol Phys· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD8+ and FoxP3+ T-Cell Cellular Density and Spatial Distribution After Programmed Death-Ligand 1 Check Point Inhibition.
Joseph Curry, Angela Alnemri, Ramez Philips, Michele Fiorella, Sarah Sussman, Athanassios Argiris

Laryngoscope· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab and ipilimumab in combination with radiotherapy in patients with high-risk locally advanced squamous cell carcinoma of the head and neck.
Jennifer M Johnson, Ioannis A Vathiotis, Larry A Harshyne, Ayesha Ali, Voichita Bar Ad, Athanassios Argiris

J Immunother Cancer· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab Plus Ipilimumab Versus EXTREME Regimen as First-Line Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: The Final Results of CheckMate 651.
Robert I Haddad, Kevin Harrington, Makoto Tahara, Robert L Ferris, Maura Gillison, Athanassios Argiris

J Clin Oncol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Programmed cell death protein 1 axis blockade in locally advanced squamous cell carcinoma of the head and neck: Neoadjuvant and adjuvant approaches.
Ioannis A Vathiotis, Jennifer M Johnson, Adam Luginbuhl, David Cognetti, Joseph Curry, Athanassios Argiris

Cancer Treat Rev· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant Apatinib in Nasopharyngeal Carcinoma With Residual Epstein-Barr Virus DNA After Radiation Therapy: A Biomarker-Driven, Phase 2 Trial.
Xu Liu, Ling Guo, Fang-Yun Xie, Wei-Han Hu, Ming-Yuan Chen, Athanassios Argiris

Int J Radiat Oncol Biol Phys· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tadalafil Enhances Immune Signatures in Response to Neoadjuvant Nivolumab in Resectable Head and Neck Squamous Cell Carcinoma.
Adam J Luginbuhl, Jennifer M Johnson, Larry A Harshyne, Alban J Linnenbach, Sanket K Shukla, Athanassios Argiris

Clin Cancer Res· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting Angiogenesis in Squamous Cell Carcinoma of the Head and Neck: Opportunities in the Immunotherapy Era.
Nabil F Saba, Pooja Vijayvargiya, Jan B Vermorken, Juan P Rodrigo, Stefan M Willems, Athanassios Argiris

Cancers (Basel)· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nasopharyngeal cancer in non-endemic areas: Impact of treatment intensity within a large retrospective multicentre cohort.
Paolo Bossi, Annalisa Trama, Alice Bernasconi, Salvatore Grisanti, Issa Mohamad, Athanassios Argiris

Eur J Cancer· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Dose-finding Study Followed by a Phase II Randomized, Placebo-controlled Trial of Chemoradiotherapy With or Without Veliparib in Stage III Non-small-cell Lung Cancer: SWOG 1206 (8811).
Athanassios Argiris, Jieling Miao, Mihaela C Cristea, Allen M Chen, Jacob M Sands

Clin Lung Cancer· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preoperative Immunotherapy in the Multidisciplinary Management of Oral Cavity Cancer.
Ramez Philips, Chihun Han, Brian Swendseid, Joseph Curry, Athanassios Argiris

Front Oncol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing programmed cell death protein 1 axis inhibition in head and neck squamous cell carcinoma: Combination immunotherapy.
Ioannis A Vathiotis, Jennifer M Johnson, Athanassios Argiris

Cancer Treat Rev· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group.
Benjamin Lacas, Alexandra Carmel, Cécile Landais, Stuart J Wong, Lisa Licitra, Athanassios Argiris

Radiother Oncol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of brief symptom indexes among patients with recurrent or metastatic squamous cell carcinoma of the head and neck: A trial of the ECOG-ACRIN Cancer Research Group (E1302).
Laura B Oswald, Ju-Whei Lee, Athanassios Argiris, Kimberly A Webster, Arlene A Forastiere

Cancer Med· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discordant Responses Between Primary Head and Neck Tumors and Nodal Metastases Treated With Neoadjuvant Nivolumab: Correlation of Radiographic and Pathologic Treatment Effect.
Dante J Merlino, Jennifer M Johnson, Madalina Tuluc, Stacey Gargano, Robert Stapp, Athanassios Argiris

Front Oncol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An update on angiogenesis targeting in head and neck squamous cell carcinoma.
Ida Micaily, Jennifer Johnson, Athanassios Argiris

Cancers Head Neck· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase III Randomized Trial of Chemotherapy With or Without Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer.
Athanassios Argiris, Shuli Li, Panayiotis Savvides, James P Ohr, Jill Gilbert

J Clin Oncol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Advances in the Systemic Therapy and Combined Modality Approaches for Head and Neck Cancer.
Athanassios Argiris, Lisa Licitra

Front Oncol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis